Literature DB >> 6423368

Immunocytochemical localization of growth hormone-releasing factor in the rat hypothalamus.

I Merchenthaler, S Vigh, A V Schally, P Petrusz.   

Abstract

The distribution of GRF-immunoreactive structures in the rat hypothalamus was studied after colchicine treatment with peroxidase-antiperoxidase immunocytochemistry in vibratome sections. The majority of the GRF-immunoreactive cell bodies were found in the arcuate nucleus and the medial perifornical region of the lateral hypothalamus. Scattered cells were seen in the lateral basal hypothalamus, the medial and lateral portions of the ventromedial nucleus, and the dorsomedial and paraventricular nuclei. Fibers from the perifornical cell bodies formed a fan-like projection to the median eminence, where a dense accumulation of GRF-containing processes and terminals was found. GRF terminals were located in the central regions of the median eminence. The localization of GRF-immunoreactive structures in the hypothalamus and median eminence reinforces the view that GRF plays a physiological role in the regulation of pituitary function.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6423368     DOI: 10.1210/endo-114-4-1082

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  16 in total

1.  Light-microscopic immunocytochemical localization of growth hormone-releasing factor in the human hypothalamus.

Authors:  G Pelletier; L Désy; J Côté; G Lefèvre; H Vaudry
Journal:  Cell Tissue Res       Date:  1986       Impact factor: 5.249

Review 2.  Neurobiological mechanisms for the regulation of mammalian sleep-wake behavior: reinterpretation of historical evidence and inclusion of contemporary cellular and molecular evidence.

Authors:  Subimal Datta; Robert Ross Maclean
Journal:  Neurosci Biobehav Rev       Date:  2007-03-12       Impact factor: 8.989

Review 3.  Chemical modification of class II G protein-coupled receptor ligands: frontiers in the development of peptide analogs as neuroendocrine pharmacological therapies.

Authors:  Megan C Chapter; Caitlin M White; Angela DeRidder; Wayne Chadwick; Bronwen Martin; Stuart Maudsley
Journal:  Pharmacol Ther       Date:  2009-08-15       Impact factor: 12.310

4.  Synaptic communication between somatostatinergic axons and growth hormone-releasing factor (GRF) synthesizing neurons in the arcuate nucleus of the rat.

Authors:  Z Liposits; I Merchenthaler; W K Paull; B Flerkó
Journal:  Histochemistry       Date:  1988

Review 5.  Cellular and chemical neuroscience of mammalian sleep.

Authors:  Subimal Datta
Journal:  Sleep Med       Date:  2010-03-31       Impact factor: 3.492

6.  Hypothalamic catecholamine histofluorescence in dwarf mice.

Authors:  C J Phelps; J R Sladek; W W Morgan; A Bartke
Journal:  Cell Tissue Res       Date:  1985       Impact factor: 5.249

7.  Unexpected thymic hyperplasia in transgenic mice harboring a neuronal promoter fused with simian virus 40 large T antigen.

Authors:  F M Botteri; H van der Putten; D F Wong; C A Sauvage; R M Evans
Journal:  Mol Cell Biol       Date:  1987-09       Impact factor: 4.272

Review 8.  Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects.

Authors:  Monica Gola; Mauro Doga; Stefania Bonadonna; Gherardo Mazziotti; Pier Paolo Vescovi; Andrea Giustina
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

9.  Failure to demonstrate disruption of ultradian growth hormone rhythm and insulin secretion by dorsomedial hypothalamic nucleus lesions that cause reduced body weight, linear growth and food intake.

Authors:  L L Bernardis; G S Tannenbaum
Journal:  Exp Brain Res       Date:  1987       Impact factor: 1.972

10.  Ontogenetic appearance of immunoreactive GRF-containing neurons in the rat hypothalamus.

Authors:  S Daikoku; H Kawano; M Noguchi; M Tokuzen; K Chihara; H Saito; T Shibasaki
Journal:  Cell Tissue Res       Date:  1985       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.